These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Subacute cutaneous lupus erythematosus induced by terbinafine: case report and review of literature. Lorentz K, Booken N, Goerdt S, Goebeler M. J Dtsch Dermatol Ges; 2008 Oct 01; 6(10):823-7, 823-8. PubMed ID: 18564209 [Abstract] [Full Text] [Related]
32. An uncommon cutaneous reaction for a common drug. Diagnosis: Drug-induced subacute cutaneous lupus erythematosus (DI-SCLE). Kwong HL, Teo RY. Ann Acad Med Singap; 2014 Aug 01; 43(8):433-4. PubMed ID: 25244994 [No Abstract] [Full Text] [Related]
34. Cutaneous lupus associated with pembrolizumab therapy for advanced melanoma: a report of three cases. Blakeway EA, Elshimy N, Muinonen-Martin A, Marples M, Mathew B, Mitra A. Melanoma Res; 2019 Jun 01; 29(3):338-341. PubMed ID: 30762712 [Abstract] [Full Text] [Related]
35. Drug-induced subacute cutaneous lupus erythematosus related to doxycycline. Miller KK, Chu J, Patel R, Kamino H. Dermatol Online J; 2011 Oct 15; 17(10):3. PubMed ID: 22031629 [Abstract] [Full Text] [Related]
36. Drug-induced subacute cutaneous lupus erythematosus associated with docetaxel chemotherapy: a case report. Wong NY, Parsons LM, Trotter MJ, Tsang RY. BMC Res Notes; 2014 Nov 05; 7():785. PubMed ID: 25369825 [Abstract] [Full Text] [Related]